Systematic review & meta-analysis
Low skeletal muscle mass index associated with 57% higher all-cause mortality risk (pooled RR 1.57, 95% CI 1.25–1.96) across 16 prospective studies, 81,358 participants
Meta-analysis
Vs BMI 22.5–<25: obesity 30–<35 HR 1.45; 35–<40 HR 1.94; 40–<60 HR 2.76
Global BMI Mortality Collaboration · Lancet · 2016 · PMID 27423262
Read the study →
Systematic review & meta-analysis
~10 mmHg SBP lowering in RCT meta-analysis reduced all-cause mortality RR 0.87; observational 20 mmHg higher usual SBP materially increased vascular mortality
Moderate–strong predictor
Meta-analysis
~9% higher mortality per +10 bpm in meta-analysis; UK Biobank ~19–22% higher per +10 bpm
Meta-analysis
Highest vs lowest GGT quartile associated with 56% higher all-cause mortality (pooled RR 1.56, 95% CI 1.34–1.83) across 7 prospective cohorts, 273,141 participants
Observational study
Adjusted death risk rose stepwise as eGFR fell below 60 mL/min/1.73m2, from HR 1.2 (eGFR 45–59) up to HR 5.9 (eGFR <15), in a cohort of 1.12 million adults
Cohort study
1-SD decrement in low-frequency HRV power associated with 1.70x greater all-cause mortality hazard (95% CI 1.37–2.09) over 4 years in an elderly community cohort